AI-extracted from the 10-Q filed 2026-07-29 — Q2 FY2026 (quarter ended June 30, 2026). Every figure is machine-verified against the filing text on SEC EDGAR.
Revenue rose 4.5% YoY to $5.48B in Q2 FY2026, led by 12% Financial Services growth, while Cognizant launched a new Project Leap restructuring ($230-320M) and borrowed $1B to fund acquisitions and buybacks.
Biggest Revenue Drivers
Financial Services$1,733M+12.0% YoY
Ramp up of several recently won large deals and increasing demand for intuitive operations and automation and AI/analytics services
Health Sciences$1,572M+1.4% YoY
Biggest Revenue Drivers
Total revenue: $5.48B+4.5% YoY
Financial Services$1,733M+12.0% YoY
Ramp up of several recently won large deals and increasing demand for intuitive operations and automation and AI/analytics services
Health Sciences$1,572M+1.4% YoY
Products and Resources$1,322M+1.2% YoY
Softer discretionary spend among retail, consumer goods, travel and hospitality customers, partially offset by manufacturing, logistics, energy and utilities demand
Communications, Media and Technology$854M+1.5% YoY
Weakness among communications and media customers offset by growth in technology customers, primarily in North America
Largest Expense Items
Cost of revenues$3,652M+5.0% YoY
Impact of sale of third-party products in integrated offerings strategy and increased compensation costs, partly offset by favorable FX
Selling, general and administrative expenses$728M-10.1% YoY
$81 million partial reversal of the 2019 India Defined Contribution Obligation liability and operational efficiencies, partly offset by dilutive impact of recent acquisitions
Depreciation and amortization$143M+2.9% YoY
Amortization expense from intangible assets related to recently completed acquisitions
Restructuring charges$84M
Employee separation and other costs related to newly initiated Project Leap program
Margins: GAAP operating margin rose to 15.9% from 15.6% YoY, helped by operational efficiencies and favorable FX, partly offset by higher compensation costs, acquisition dilution, and third-party product sales mix; margin also included an $84M Project Leap charge offset by an $81M India benefit reversal.
Watch Items from the Filing
New Project Leap program expects total costs of $230-320M (mostly in 2026) targeting $200-300M of in-year savings; actual costs/savings may differ materially.
In the CDCA discrimination class action, a jury found liability and the court awarded plaintiffs $16 million in interim attorneys' fees; Cognizant cannot estimate a possible loss for the remaining class and has recorded no accrual.
India tax authority asserts an additional 33 billion rupees (~$349M at June 30, 2026 rates) owed on a 2016 share repurchase; case remains in litigation with no reserves recorded.
DSO increased to 88 days as of June 30, 2026 from 81 days at December 31, 2025, indicating slower receivables collection.
AI-extracted and verified against SEC EDGAR filing text. Not investment advice.
Schot AbrahamDirectorGrant or award · Aug 25, 2026
Congress trading in CTSH
22 transactions in CTSH reported by 8 members of Congress under the STOCK Act, most recent trade Apr 14, 2026. Reported transactions, not recommendations.
About COGNIZANT TECHNOLOGY SOLUTIONS CORP (CTSH): stock profile, AI score and financials
COGNIZANT TECHNOLOGY SOLUTIONS CORP (CTSH) stock profile, AI quality score, and SEC EDGAR financial data, a Technology sector company. 13F Pro's AI-powered ranking engine scores CTSH at 64.5/100 on a composite quality score built from its SEC filings, placing it at rank #530 of 2,925 stocks — the top 25% of the AI-ranked universe. CTSH scores in the top quartile across revenue scale (93.0), institutional flow (90.9), balance sheet strength (86.9). Based on the latest XBRL financial filings (Q2 2026), COGNIZANT TECHNOLOGY SOLUTIONS CORP reports quarterly revenue of $5.5B, net income of $636.0M, an operating margin of 16.0%. Top institutional holders of CTSH by reported 13-F value include BlackRock, VANGUARD CAPITAL MANAGEMENT, PZENA INVESTMENT MANAGEMENT, based on the most recent SEC filings. CTSH trades on the Nasdaq exchange and files with the SEC under CIK 1058290. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate CTSH daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for COGNIZANT TECHNOLOGY SOLUTIONS CORP directly from SEC EDGAR.